Lennar's consensus analyst price target has recently edged down from $129.07 to $127.50. This reflects a modest reduction of ...
Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...
The West Virginia Mountaineers and UCF Knights will fight Saturday afternoon for their first Big 12 Conference win this ...
MedPage Today on MSN
First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer
BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
PARK CITY, Utah — Officials from the Park City School District recently reviewed progress on the district’s five-year ...
Given the intricate nature of these technologies, enforcing detailed, granular standards throughout the development lifecycle ...
Third Quarter 2025 HighlightsNet income for the third quarter of 2025 was $9.7 million, compared to $10.4 million in the prior quarter and $9.5 ...
Momentum for economic resilience: New GCA report shows Africa’s economies demonstrating path-breaking climate readiness, with ...
Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Graduates of the Adult Practical Nursing Program at Schuylkill Technology Center North achieved an outstanding rating on the National Council Licensure Examination, officials announced. The 24 ...
Ranging in age from a tender 25 to a seasoned 39, this year’s GenNext Awards honorees work in a range of disciplines at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback